The economic architecture of the modern pharmaceutical supply chain operates as a highly complex matrix where multi-tier distribution channels, manufacturer rebate structures, third-party insurance payers, and clinical networks intersect across global healthcare markets. Within this integrated ecosystem, commercial actors—including retail pharmacy chains, institutional networks, specialized compounding facilities, mail-order hubs, and digital e-dispensaries—routinely engage in aggressive […]